Since its formation in 2011, Integral BioSystems has established credibility in drug formulation, CMC consulting, analytical method development and methods qualification, as well as scale-up process engineering. Its strong presence as an ophthalmic product development CRO allows Integral BioSystems to provide expertise and know-how in developing cost effective approaches to both front-of-the-eye and back-of-the-eye products while offering complete development services in pre-formulation, including bioanalytical.
With multiple billion dollar drug products going off-patent, Integral can help strategize cost effective ways to develop an extended product life cycle. Integral will offer its insight into drug delivery to help and improve the customer’s product portfolio. To this effect, Integral BioSystems has been a development partner for both innovative and generic companies.